BMI News & Analysis
2 articles
Market Mood
NDSN and BMI Dividend Stocks Show Strong Growth Metrics
Nordson (NDSN) reported record revenue of $669 million for Q1 2026, a 9% increase year-over-year, with EPS rising 44% to $2.38. The company increased its annual guidance to expected revenue between $2.86 billion and $2.98 billion and adjusted EPS of $11 to $11.60. Additionally, Nordson has increased its dividend for 62 consecutive years, currently yielding 1.22%. Badger Meter (BMI) also performed well with 2025 sales of $916.7 million, up 11%, and EPS up 13% to $4.79, attributing growth to a 27% rise in SaaS sales and contributions from its SmartCover acquisition.
Read More
Reevaluating Obesity: GLP-1s Spark Debate Over BMI's Accuracy
Recent discussions around obesity have highlighted the shortcomings of the Body Mass Index (BMI) as an indicator of health, particularly as millions now turn to GLP-1 medications for weight management. This shift raises questions about how obesity is defined and measured, which could have broader implications for healthcare policy and market dynamics in the pharmaceutical sector. With the growing prevalence of GLP-1 use, companies developing these treatments may see increased demand, impacting stock valuations and healthcare expenditures. Investors should monitor the potential shifts in health metrics and treatment approaches that could influence market strategies.
Read More